Ticker
RGNXCompany Name
REGENXBIO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Buyback Yield | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares |
---|---|---|---|
6/30/2025 | -0.22% | $ 399.06M | $ 884K |
3/31/2025 | -0.22% | $ 399.78M | $ 861K |
12/31/2024 | -40.68% | $ 328.06M | $ 133.45M |
9/30/2024 | -28.67% | $ 467.21M | $ 133.94M |
6/30/2024 | -21.17% | $ 657.82M | $ 139.26M |
3/31/2024 | -17.06% | $ 821.1M | $ 140.06M |
12/31/2023 | -0.92% | $ 889.44M | $ 8.22M |
9/30/2023 | -1.12% | $ 721.91M | $ 8.05M |
6/30/2023 | -0.47% | $ 830.85M | $ 3.88M |
3/31/2023 | -0.53% | $ 879.32M | $ 4.64M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity) / Market Cap
(=) Buyback Yield
Buyback Yield for REGENXBIO INC is calculated as follows: (-1 * CF - Equity [ $ 7.59M ]) / Market Cap [ $ 1.16B ]
(=) Buyback Yield [ -0.65% ]
Minimum
Dec 31, 2024
Maximum
Mar 31, 2025
Average
Median
filtered constituents | 3.28K |
---|---|
min | -8.43% |
max | 8.46% |
average | 0.64% |
median | 0.01% |
std | 2.71% |